Literature DB >> 21790848

Polidocanol concentration and time affect the properties of foam used for sclerotherapy.

Brend VAN Deurzen1, Roeland P Ceulen, Sarah S Tellings, Cees VAN DER Geld, Tamar Nijsten.   

Abstract

BACKGROUND: How foam is created for sclerotherapy varies and is not standardized. Moreover, the effect of several factors on the quality of the foam is not well studied.
OBJECTIVE: To investigate the effects of different parameters on foam stability and bubble size.
METHODS: As a measure of foam stability, foam half time (FHT) and bubble size distribution were determined for various parameters (polidocanol (POL) concentration, freshness of the POL, syringe size, liquid-to-air ratio, number of pump cycles, and needle size) in the foam creation process.
RESULTS: FHT was 115 to 157 seconds for POL 1% and 143 to 192 seconds for POL 3%. The other parameters had a limited effect on FHT. POL foam 1% (t=0 seconds) had a mean bubble size of 71 ± 9 μm that increased when the foam was maintained horizontally in the syringe: 102 ± 12 μm) at 30 seconds and 121 ± 20 μm at 60 seconds. The other parameters had no significant influence on bubble size distribution.
CONCLUSIONS: Higher concentration of POL and rapid injection optimize foam stability and bubble size distribution, but other important foam characteristics are largely independent of differences in the generation and injection of foam. The authors have indicated no significant interest with commercial supporters.
© 2011 by the American Society for Dermatologic Surgery, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21790848     DOI: 10.1111/j.1524-4725.2011.02095.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  4 in total

1.  Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.

Authors:  Dario Carugo; Dyan N Ankrett; Xuefeng Zhao; Xunli Zhang; Martyn Hill; Vincent O'Byrne; James Hoad; Mehreen Arif; David D I Wright; Andrew L Lewis
Journal:  Phlebology       Date:  2015-06-01       Impact factor: 1.740

2.  In vitro and ex vivo evaluation of the biological performance of sclerosing foams.

Authors:  Elisabetta Bottaro; Jemma A J Paterson; Luciano Quercia; Xunli Zhang; Martyn Hill; Venisha A Patel; Stephen A Jones; Andrew L Lewis; Timothy M Millar; Dario Carugo
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

3.  The role of clinically-relevant parameters on the cohesiveness of sclerosing foams in a biomimetic vein model.

Authors:  Dario Carugo; Dyan N Ankrett; Vincent O'Byrne; David D I Wright; Andrew L Lewis; Martyn Hill; Xunli Zhang
Journal:  J Mater Sci Mater Med       Date:  2015-10-08       Impact factor: 3.896

4.  A modified Tessari method for producing more foam.

Authors:  Jie Xu; Yi-Fei Wang; An-Wei Chen; Tao Wang; Shao-Hua Liu
Journal:  Springerplus       Date:  2016-02-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.